The Effect of Virtual Reality Applications
Launched by DICLE UNIVERSITY · Jan 24, 2025
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how using virtual reality (VR) can help reduce pain, stress, and fear during a medical procedure called fine needle aspiration biopsy, which is often used to check for thyroid cancer. Many people have thyroid nodules, which are lumps on the thyroid gland, and the biopsy can be uncomfortable. The trial will test whether watching a motivational video through VR glasses can distract patients and make the procedure easier for them.
To participate in this study, you should be an adult who has a suspected thyroid mass and does not have issues with dizziness or vision. However, if you have mental health problems that might prevent you from wearing VR glasses, you would not be eligible. Participants can expect to wear VR glasses during their biopsy to see if it helps them feel less pain and anxiety. This trial is not yet recruiting, so keep an eye out for updates if you or someone you know might be interested in joining.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with suspected thyroid mass
- • No dizziness problem
- • No vision problems
- Exclusion Criteria:
- • Mental health problems that may prevent wearing virtual reality glasses
About Dicle University
Dicle University is a prominent academic institution located in the southeastern region of Turkey, dedicated to advancing medical research and education. With a strong commitment to improving healthcare outcomes, Dicle University actively sponsors clinical trials that aim to explore innovative treatments and enhance patient care. The university's multidisciplinary approach fosters collaboration among researchers, healthcare professionals, and students, ensuring that clinical studies are conducted with rigor and integrity. Through its clinical trial initiatives, Dicle University strives to contribute valuable insights to the scientific community and support the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Diyarbakır, South East, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported